Revenio Group OyjCHIX:REG1VH 77 Gross Margin % is 68.50% as of Mar. 2026, which is 3% below its 10-year median of 70.96. GuruFocus rates CHIX:REG1VH with a GF Score™ of 77/100 and a GF Value™ of €40.41. The stock has 2 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Revenio Group Oyj ranks better than 79.63% on this metric.
The historical rank and industry rank for Revenio Group Oyj's Gross Margin % or its related term are showing as below:
CHIX:REG1Vh'
s Gross Margin % Range Over the Past 10 Years
Min: 69.81 Med: 70.96 Max: 74.45
Current: 69.88
During the past 13 years, the highestGross Margin % of Revenio Group Oyj was 74.45%. The lowest was 69.81%. And the median was 70.96%.
CHIX:REG1Vh's Gross Margin % is ranked better than 79.63% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs CHIX:REG1Vh: 69.88
Revenio Group Oyj had a gross margin of 68.50% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Revenio Group Oyj was -0.10% per year.
Revenio Group Oyj (CHIX:REG1Vh) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Revenio Group Oyj had a gross margin of 68.50% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Revenio Group Oyj Gross Margin % Related Terms
Revenio Group Oyj Gross Margin % Historical Data
* Premium members only.
The historical data trend for Revenio Group Oyj's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:REG1VH vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Revenio Group Oyj's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Revenio Group Oyj Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Revenio Group Oyj's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Revenio Group Oyj's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Revenio Group Oyj (CHIX:REG1VH) has a Gross Margin % of 68.50% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Revenio Group Oyj and its competitors. This is near median its historical median of 70.96. Over the past decade, Revenio Group Oyj's Gross Margin % has ranged from 69.81 to 74.45. According to the industry distribution chart, Revenio Group Oyj ranks #164 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 20.4%.
Is Revenio Group Oyj's Gross Margin % too high?
Revenio Group Oyj's current Gross Margin % of 68.50% is near median its 10-year median of 70.96. Over the past 10 years, this metric has ranged from a low of 69.81 to a high of 74.45. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Revenio Group Oyj's value of 68.50% is 31.6% above this industry median. Based on the distribution chart, Revenio Group Oyj ranks #164 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Revenio Group Oyj has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Revenio Group Oyj's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Revenio Group Oyj ranks #164 out of 805 companies for Gross Margin %. This places Revenio Group Oyj in the top 20% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.07. Revenio Group Oyj's value of 68.50% is 31.6% above this benchmark. Historically, Revenio Group Oyj's own Gross Margin % has ranged from 69.81 to 74.45 over the past decade. While the company's 10-year median is 70.96 vs. the industry median of 52.07, Revenio Group Oyj has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Revenio Group Oyj's current Gross Margin % of 68.50% is 31.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Revenio Group Oyj and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Revenio Group Oyj's current Gross Margin % is 68.50%, which is near median its own 10-year median of 70.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revenio Group Oyj stock overvalued right now?
Revenio Group Oyj (CHIX:REG1VH) has a current Gross Margin % of 68.50%. The stock's GF Value™ is €40.41, compared to a current price of €16.47 — trading 59.2% below its estimated fair value. The current Gross Margin % is 68.50%, which is near median its 10-year median of 70.96 and 31.6% above the Medical Devices & Instruments industry median of 52.07. Revenio Group Oyj's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Revenio Group Oyj (CHIX:REG1VH), the current Gross Margin % is 68.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Revenio Group Oyj (CHIX:REG1VH) Overvalued in 2026?
Based on GuruFocus' analysis, Revenio Group Oyj stock appears to be undervalued.
The current stock price of €16.47 is trading 59.2% below its estimated GF Value™ of €40.41.
Key valuation signals for CHIX:REG1VH:
Gross Margin %: 68.50% (near median its 10-year median of 70.96)
GF Value™: €40.41 vs. price of €16.47 (59.2% below fair value)
Industry Position: 31.6% above the Medical Devices & Instruments median (#164 of 805)
No single metric tells the full story. See the CHIX:REG1VH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective, easy-to-use health tech-related screening devices for detecting diseases of public health significance. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), and perimeter and fundus imaging devices under the iCare brand. Its eye care software platform, Oculo, offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company generates the majority of its revenue from the United States.
77GF Score
Get the complete analysis for CHIX:REG1VH
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:REG1VH has been successfully added to your 
